AC
CBIO

Athanor Capital’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Athanor Capital’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-479
Closed -$147K – 699
2020
Q3 		$147K Sell
479
-235
-33% -$72.1K 0.01% 492
2020
Q2 		$268K Buy
714
+400
+127% +$150K 0.01% 418
2020
Q1 		$72K Sell
314
-282
-47% -$64.7K ﹤0.01% 142
2019
Q4 		$315K Buy
+596
New +$315K 0.01% 267